AZD5863 - AstraZeneca
AZD5863: Data from P1 trial (NCT06005493) for solid tumors in H1 2027 (AstraZeneca) - Jul 27, 2026 - H1 & Q2 2026 Results 
P1 data • Oncology • Solid Tumor
https://www.astrazeneca.com/investor-relations/h1-and-q2-2026-results-event.html
 
Jul 27, 2026
 
 
57aa3643-4319-4d07-9ffd-c41721e80b7e.png